company background image
PRE

Prenetics Global NasdaqGM:PRE Stock Report

Last Price

US$3.97

Market Cap

US$440.6m

7D

-0.5%

1Y

-47.3%

Updated

16 Aug, 2022

Data

Company Financials +
PRE fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance0/6
Financial Health2/6
Dividends0/6

PRE Stock Overview

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company.

Prenetics Global Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Prenetics Global
Historical stock prices
Current Share PriceUS$3.97
52 Week HighUS$8.75
52 Week LowUS$3.39
Beta0
1 Month Change0%
3 Month Change-48.11%
1 Year Change-47.31%
3 Year Changen/a
5 Year Changen/a
Change since IPO-48.94%

Recent News & Updates

Shareholder Returns

PREUS BiotechsUS Market
7D-0.5%1.8%4.5%
1Y-47.3%-22.2%-8.9%

Return vs Industry: PRE underperformed the US Biotechs industry which returned -19.6% over the past year.

Return vs Market: PRE underperformed the US Market which returned -9.6% over the past year.

Price Volatility

Is PRE's price volatile compared to industry and market?
PRE volatility
PRE Average Weekly Movement12.5%
Biotechs Industry Average Movement12.5%
Market Average Movement7.6%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: PRE is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week.

Volatility Over Time: PRE's weekly volatility has increased from 6% to 13% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2014800Danny Yeunghttps://www.prenetics.com

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company’s products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem.

Prenetics Global Limited Fundamentals Summary

How do Prenetics Global's earnings and revenue compare to its market cap?
PRE fundamental statistics
Market CapUS$440.59m
Earnings (TTM)-US$208.91m
Revenue (TTM)US$310.44m

1.4x

P/S Ratio

-2.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PRE income statement (TTM)
RevenueUS$310.44m
Cost of RevenueUS$190.21m
Gross ProfitUS$120.23m
Other ExpensesUS$329.15m
Earnings-US$208.91m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.88
Gross Margin38.73%
Net Profit Margin-67.29%
Debt/Equity Ratio-124.5%

How did PRE perform over the long term?

See historical performance and comparison